New research from Cedars-Sinai’s Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the drug as a preventive measure against the disease.
Antibody treatment shields transplant patients against COVID-19
- Post author:
- Post published:December 18, 2023
- Post category:uncategorized